EquityZen Growth Technology Fund LLC - Series 868
Raised
$122K
Investors
4
Min Invest
$10,007
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 868 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC on 2021-06-16, raising $122K from 4 investors under Rule 506(b) and Section 3(c)(1) exemptions. The fund requires a $10K minimum investment and is part of EquityZen's pre-IPO investment platform, which operates 1,889 related EDGAR entities providing access to private company shares.
This pre-IPO fund uses the standard 506(b)/3(c)(1) exemption structure typical of private securities platforms, with a $10K minimum investment positioning it as retail-accessible compared to institutional-only vehicles. The $30.5K average commitment across 4 investors reflects EquityZen's model of aggregating smaller investors into single-company SPVs for late-stage private equity access.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.